{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:43:00Z","timestamp":1784234580017,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.biomaterials.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T14:26:58Z","timestamp":1557239218000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium"],"prefix":"10.1016","volume":"212","author":[{"given":"Mehmet H.","family":"Kural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Leiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tellides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Mark","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Niklason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biomaterials.2019.05.011_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7150\/thno.7210","article-title":"Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis","volume":"4","author":"Yin","year":"2014","journal-title":"Theranostics"},{"issue":"2 Pt 1","key":"10.1016\/j.biomaterials.2019.05.011_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-8703(96)90442-1","article-title":"Management of restenosis after coronary intervention","volume":"132","author":"Dangas","year":"1996","journal-title":"Am. Heart J."},{"issue":"24","key":"10.1016\/j.biomaterials.2019.05.011_bib3","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199706123362402","article-title":"Catheter-based radiotherapy to inhibit restenosis after coronary stenting","volume":"336","author":"Teirstein","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.biomaterials.2019.05.011_bib4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.05.011_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cardiores.2007.06.023","article-title":"The role of the adventitia in vascular inflammation","volume":"75","author":"Maiellaro","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biomaterials.2019.05.011_bib6","doi-asserted-by":"crossref","unstructured":"Kramann, R., et al., Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell. 19(5): p. 628-642.","DOI":"10.1016\/j.stem.2016.08.001"},{"issue":"8","key":"10.1016\/j.biomaterials.2019.05.011_bib7","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/ATVBAHA.115.306088","article-title":"Adventitia and perivascular cells","volume":"35","author":"Majesky","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2013.01.020","article-title":"Inception to actualization: next generation coronary stent coatings incorporating nanotechnology","volume":"164","author":"Tan","year":"2013","journal-title":"J. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.med.55.091902.105243","article-title":"Drug-eluting stents","volume":"55","author":"Woods","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcin.2013.09.008","volume":"7","author":"Valgimigli","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"13","key":"10.1016\/j.biomaterials.2019.05.011_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation","volume":"65","author":"Giustino","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.05.011_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003803","article-title":"Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model","volume":"5","author":"Nakazawa","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCINTERVENTIONS.110.957654","article-title":"Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis","volume":"4","author":"Nakazawa","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.05.011_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4244\/EIJ-D-16-00787","article-title":"Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study","volume":"13","author":"Song","year":"2017","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib16","first-page":"425","article-title":"Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: insights from the National VA CART Program","volume":"91","author":"Waldo","year":"2017","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.05.011_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"issue":"5203","key":"10.1016\/j.biomaterials.2019.05.011_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1073\/pnas.95.3.1213","article-title":"Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell\u2009response","volume":"95","author":"Sata","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.05.011_bib21","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.4049\/jimmunol.166.11.6964","article-title":"Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia","volume":"166","author":"Sata","year":"2001","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.biomaterials.2019.05.011_bib22","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.99.14.1776","article-title":"Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals","volume":"99","author":"Luo","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.05.011_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm0498-415","article-title":"TNF[alpha] regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation","volume":"4","author":"Sata","year":"1998","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.05.011_bib24","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/eji.1830241111","article-title":"Fas ligation triggers apoptosis in macrophages but not endothelial cells","volume":"24","author":"Richardson","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.05.011_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.ATV.20.2.309","article-title":"Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy","volume":"20","author":"Sata","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6638","key":"10.1016\/j.biomaterials.2019.05.011_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.biomaterials.2019.05.011_bib27","doi-asserted-by":"crossref","first-page":"17255","DOI":"10.1074\/jbc.272.28.17255","article-title":"I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis","volume":"272","author":"Hu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.biomaterials.2019.05.011_bib28","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.1074\/jbc.M211707200","article-title":"Endothelial cell overexpression of Fas ligand attenuates ischemia-reperfusion injury in the heart","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3 Pt 2","key":"10.1016\/j.biomaterials.2019.05.011_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.HYP.27.3.823","article-title":"Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle","volume":"27","author":"Fukuo","year":"1996","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.biomaterials.2019.05.011_bib30","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.ATV.0000033517.48444.1A","article-title":"Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas\/Fas-L interactions","volume":"22","author":"Boyle","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.05.011_bib31","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1073\/pnas.93.6.2442","article-title":"Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53","volume":"93","author":"Forrester","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5387","key":"10.1016\/j.biomaterials.2019.05.011_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.282.5387.290","article-title":"Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis","volume":"282","author":"Bennett","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jbm.a.10599","article-title":"Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation","volume":"67","author":"Higgins","year":"2003","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.05.011_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(90)90612-F","article-title":"Controlled release of nerve growth factor from a polymeric implant","volume":"515","author":"Powell","year":"1990","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.05.011_bib35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/0963689718792201","article-title":"An ex vivo vessel injury model to study remodeling","volume":"27","author":"Kural","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.biomaterials.2019.05.011_bib36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.actbio.2016.12.039","article-title":"Ex vivo blood vessel bioreactor for analysis of the biodegradation of magnesium stent models with and without vessel wall integration","volume":"50","author":"Wang","year":"2017","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.05.011_bib37","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1089\/ten.tea.2008.0526","article-title":"Development of decellularized human umbilical arteries as small-diameter vascular grafts","volume":"15","author":"Gui","year":"2009","journal-title":"Tissue Eng."},{"key":"10.1016\/j.biomaterials.2019.05.011_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40001-015-0150-4","article-title":"Rapamycin impairs endothelial cell function in human internal thoracic arteries","volume":"20","author":"Reineke","year":"2015","journal-title":"Eur. J. Med. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2019.05.011_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/77521","article-title":"Fas\/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells","volume":"6","author":"Schaub","year":"2000","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.05.011_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.109.208389","article-title":"Vascular smooth muscle cell apoptosis induces interleukin-1\u2013directed inflammation","volume":"106","author":"Clarke Murray","year":"2010","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.05.011_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.biomaterials.2019.05.011_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1006\/jmcc.2000.1176","article-title":"Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels","volume":"32","author":"Sata","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.05.011_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1160\/TH10-09-0566","article-title":"High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis","volume":"105","author":"Katsaros","year":"2011","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.biomaterials.2019.05.011_bib44","series-title":"Cardiovascular Intervention: A Companion to Braunwald's Heart Disease","author":"Bhatt","year":"2016"},{"issue":"13","key":"10.1016\/j.biomaterials.2019.05.011_bib45","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"B\u00f8naa","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.05.011_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.fjc.0000248233.22570.8b","article-title":"Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells","volume":"48","author":"Matter","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.05.011_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/FJC.0b013e31823a39c7","article-title":"Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration","volume":"59","author":"Lavigne","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.05.011_bib48","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ajt.12669","article-title":"Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus","volume":"14","author":"Jin","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"Pt 3","key":"10.1016\/j.biomaterials.2019.05.011_bib49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1242\/jcs.03361","article-title":"Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2","volume":"120","author":"Kang-Decker","year":"2007","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.05.011_bib50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0008-6363(01)00344-3","article-title":"Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF","volume":"51","author":"Jozkowicz","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/(SICI)1097-4652(199706)171:3<252::AID-JCP3>3.0.CO;2-N","article-title":"Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation","volume":"171","author":"Gooch","year":"1997","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.05.011_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(99)00041-6","article-title":"Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP","volume":"144","author":"Heller","year":"1999","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.05.011_bib53","article-title":"Exogenous, but not endogenous nitric oxide inhibits adhesion molecule expression in human endothelial cells","volume":"3","author":"Qian","year":"2012","journal-title":"Front. Physiol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219302753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219302753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:42:45Z","timestamp":1758904965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219302753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":53,"alternative-id":["S0142961219302753"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.05.011","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}